Peer-influenced content. Sources you trust. No registration required. This is HCN.
OBR Oncology
In the evolving landscape of radiation oncology, the discussion around supervision models—direct or virtual—presents a pivotal moment for the field. This debate not only impacts patient access and safety but also stresses upon the profession’s adaptability in integrating technology while preserving core clinical standards.
Oncology, Radiation April 8th 2024
The New England Journal of Medicine
This study reinforces the noninferiority of sentinel node biopsy in patients with clinically node-negative breast cancer, offering a potential paradigm shift in surgical decision-making and patient care.
Oncology, Medical April 8th 2024
Cancer Therapy Advisor
Recent findings from the ASCO Gastrointestinal Cancers Symposium 2024 underscore the potential of innovative therapeutic combinations in enhancing outcomes for hepatocellular carcinoma patients, particularly those with unresectable or high-risk disease.
Oncology, Medical February 12th 2024
Mayo Clinic
In a significant advancement, one physician’s minimally invasive technique for treating membranous urethral strictures post-radiation therapy showcases promising outcomes, including improved urethral patency and reduced operative complications, marking a pivotal shift in patient management strategies.
Urology February 5th 2024
In the phase 3 GETUG-AFU 18 trial, high-dose radiotherapy (80 Gy) combined with long-term androgen deprivation therapy markedly improved 10-year progression-free and overall survival in high-risk prostate cancer patients, without additional toxicity.
Oncology, Medical February 5th 2024
Recent findings indicate that pre-WBRT administration of bevacizumab, etoposide, and cisplatin (BEEP) may significantly improve brain-specific progression-free survival in breast cancer patients with brain metastases.
Oncology, Medical January 16th 2024